Literature DB >> 32632900

The Ratio of ssDNA to dsDNA in Circulating Cell-Free DNA Extract is a Stable Indicator for Diagnosis of Gastric Cancer.

Xuewen Huang1, Qi Zhao2, Xianyuan An3, Jie Pan3, Lanjing Zhao3, Lanfeng Shen4, Yiqiu Xu4, Dandan Yuan4.   

Abstract

Due to the different mechanisms of cell-free DNA production, the single-stranded DNA to double-stranded DNA ratio in blood maybe different between healthy individuals and gastric cancer (GC) patients. We aimed to explore the potential application of this ratio in GC diagnosis. The plasma cell-free DNA extracts from 118 healthy individuals and 106 GC patients were prepared. The levels of single-stranded DNA or double-stranded DNA in plasma, and the single-stranded DNA to double-stranded DNA ratio on the diagnostic efficiency for GC were assessed with ROC curve. The relationships between this ratio and the clinical characteristics of GC patients were analyzed. The ratios in 63 GC patients before and after surgery were compared. In healthy individuals, the single-stranded DNA to double-stranded DNA ratio was not affected by factors including age, gender and BMI, and subjected to normal distribution (P = 0.1090). GC patients had a lower value of this ratio than healthy individuals (P < 0.0001). Considering this ratio as a GC diagnostic indicator, the area under ROC curve (AUC) was 0.923[95% confidence interval (CI):0.880-0.955]. This ratio in unresectable GC was obviously lower than that in resectable GC (P = 0.0045). There was a rank correlation between this ratio and GC TNM staging (rho = -0.266, P = 0.0058), but it had no correlation with tumor size (r = 0.14, P = 0.145). Additionally, this ratio was not affected by hemolysis and repeated freeze-thaw of blood samples, and was significantly elevated after surgery(P < 0.0001). The single-stranded DNA to double-stranded DNA ratio in plasma is a stable non-invasive indicator for GC diagnosis.

Entities:  

Keywords:  Gastric cancer; Non-invasive; Tumor biomarker; cfDNA; ssDNA to dsDNA ratio

Mesh:

Substances:

Year:  2020        PMID: 32632900     DOI: 10.1007/s12253-020-00869-1

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  33 in total

Review 1.  Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data.

Authors:  Ulrich Ronellenfitsch; Matthias Schwarzbach; Ralf Hofheinz; Peter Kienle; Meinhard Kieser; Tracy E Slanger; Bryan Burmeister; David Kelsen; Donna Niedzwiecki; Christoph Schuhmacher; Susan Urba; Cornelis van de Velde; Thomas N Walsh; Marc Ychou; Katrin Jensen
Journal:  Eur J Cancer       Date:  2013-06-22       Impact factor: 9.162

2.  Long-term survival after endoscopic resection versus surgery in early gastric cancers.

Authors:  Young-Il Kim; Young-Woo Kim; Il Ju Choi; Chan Gyoo Kim; Jong Yeul Lee; Soo-Jeong Cho; Bang Wool Eom; Hong Man Yoon; Keun Won Ryu; Myeong-Cheorl Kook
Journal:  Endoscopy       Date:  2015-01-27       Impact factor: 10.093

Review 3.  Integrating liquid biopsies into the management of cancer.

Authors:  Giulia Siravegna; Silvia Marsoni; Salvatore Siena; Alberto Bardelli
Journal:  Nat Rev Clin Oncol       Date:  2017-03-02       Impact factor: 66.675

Review 4.  Epidemiology of gastrointestinal and liver tumors.

Authors:  László Herszényi; Zsolt Tulassay
Journal:  Eur Rev Med Pharmacol Sci       Date:  2010-04       Impact factor: 3.507

5.  Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA.

Authors:  Muhammed Murtaza; Sarah-Jane Dawson; Dana W Y Tsui; Davina Gale; Tim Forshew; Anna M Piskorz; Christine Parkinson; Suet-Feung Chin; Zoya Kingsbury; Alvin S C Wong; Francesco Marass; Sean Humphray; James Hadfield; David Bentley; Tan Min Chin; James D Brenton; Carlos Caldas; Nitzan Rosenfeld
Journal:  Nature       Date:  2013-04-07       Impact factor: 49.962

6.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

7.  Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer.

Authors:  Inessa Skrypkina; Liudmyla Tsyba; Kateryna Onyshchenko; Dmytro Morderer; Olena Kashparova; Oleksii Nikolaienko; Grigory Panasenko; Sergii Vozianov; Alina Romanenko; Alla Rynditch
Journal:  Dis Markers       Date:  2016-09-20       Impact factor: 3.434

Review 8.  How I treat gastric adenocarcinoma.

Authors:  Maria Alsina; Josep Maria Miquel; Marc Diez; Sandra Castro; Josep Tabernero
Journal:  ESMO Open       Date:  2019-07-05

9.  Single-stranded DNA library preparation uncovers the origin and diversity of ultrashort cell-free DNA in plasma.

Authors:  Philip Burnham; Min Seong Kim; Sean Agbor-Enoh; Helen Luikart; Hannah A Valantine; Kiran K Khush; Iwijn De Vlaminck
Journal:  Sci Rep       Date:  2016-06-14       Impact factor: 4.379

10.  Cancer survival in China, 2003-2005: a population-based study.

Authors:  Hongmei Zeng; Rongshou Zheng; Yuming Guo; Siwei Zhang; Xiaonong Zou; Ning Wang; Limei Zhang; Jingao Tang; Jianguo Chen; Kuangrong Wei; Suqin Huang; Jian Wang; Liang Yu; Deli Zhao; Guohui Song; Jianshun Chen; Yongzhou Shen; Xiaoping Yang; Xiaoping Gu; Feng Jin; Qilong Li; Yanhua Li; Hengming Ge; Fengdong Zhu; Jianmei Dong; Guoping Guo; Ming Wu; Lingbin Du; Xibin Sun; Yutong He; Michel P Coleman; Peter Baade; Wanqing Chen; Xue Qin Yu
Journal:  Int J Cancer       Date:  2014-10-03       Impact factor: 7.396

View more
  2 in total

1.  Plasma contains ultrashort single-stranded DNA in addition to nucleosomal cell-free DNA.

Authors:  Jordan Cheng; Marco Morselli; Wei-Lun Huang; You Jeong Heo; Thalyta Pinheiro-Ferreira; Feng Li; Fang Wei; David Chia; Yong Kim; Hua-Jun He; Kenneth D Cole; Wu-Chou Su; Matteo Pellegrini; David T W Wong
Journal:  iScience       Date:  2022-06-08

Review 2.  Biomarkers of gastric cancer: current advancement.

Authors:  Tiantian Jiang; Lin Mei; Xiao Yang; Tingkai Sun; Zhidong Wang; Yuanyuan Ji
Journal:  Heliyon       Date:  2022-10-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.